HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells.

Abstract
Allergic diseases, such as asthma and allergic rhinitis, are common. Therefore, the discovery of therapeutic drugs for these conditions is essential. Methyleugenol (ME) is a natural compound with antiallergic, antianaphylactic, antinociceptive, and anti-inflammatory effects. This study examined the antiallergic effect of ME on IgE-mediated inflammatory responses and its antiallergy mechanism in the mast cell line, RBL-2H3. We found that ME significantly inhibited the release of β-hexosaminidase, tumor necrosis factor- (TNF-) α, and interleukin- (IL-) 4, and was not cytotoxic at the tested concentrations (0-100 μM). Additionally, ME markedly reduced the production of the proinflammatory lipid mediators prostaglandin E2 (PGE2), prostaglandin D2 (PGD2), leukotriene B4 (LTB4), and leukotriene C4 (LTC4). We further evaluated the effect of ME on the early stages of the FcεRI cascade. ME significantly inhibited Syk phosphorylation and expression but had no effect on Lyn. Furthermore, it suppressed ERK1/2, p38, and JNK phosphorylation, which is implicated in proinflammatory cytokine expression. ME also decreased cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LO) phosphorylation and cyclooxygenase-2 (COX-2) expression. These results suggest that ME inhibits allergic response by suppressing the activation of Syk, ERK1/2, p38, JNK, cPLA2, and 5-LO. Furthermore, the strong inhibition of COX-2 expression may also contribute to the antiallergic action of ME. Our study provides further information about the biological functions of ME.
AuthorsFeng Tang, Feilong Chen, Xiao Ling, Yao Huang, Xiaomei Zheng, Qingfa Tang, Xiaomei Tan
JournalMediators of inflammation (Mediators Inflamm) Vol. 2015 Pg. 463530 ( 2015) ISSN: 1466-1861 [Electronic] United States
PMID25960618 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mutagens
  • Tumor Necrosis Factor-alpha
  • Leukotriene B4
  • Interleukin-4
  • Arachidonic Acid
  • methyleugenol
  • Leukotriene C4
  • Immunoglobulin E
  • Eugenol
  • Extracellular Signal-Regulated MAP Kinases
  • beta-N-Acetylhexosaminidases
  • Dinoprostone
  • Prostaglandin D2
Topics
  • Animals
  • Arachidonic Acid (metabolism)
  • Cell Line, Tumor
  • Cell Respiration
  • Dinoprostone (metabolism)
  • Eugenol (analogs & derivatives, chemistry)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Hypersensitivity (immunology)
  • Immunoenzyme Techniques
  • Immunoglobulin E (immunology)
  • Inflammation (immunology)
  • Interleukin-4 (metabolism)
  • Leukotriene B4 (metabolism)
  • Leukotriene C4 (metabolism)
  • Mast Cells (cytology)
  • Mutagens
  • Prostaglandin D2 (metabolism)
  • Rats
  • Tumor Necrosis Factor-alpha (metabolism)
  • beta-N-Acetylhexosaminidases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: